John Demaree
Overview
John Demaree received an average of $4M in total compensation, including $280K in salary, at G1 Therapeutics between 2018 and 2019.
Source: SEC filings on April 24, 2020 and April 30, 2019.
Related executives
We found nine more executives who work or worked at G1 Therapeutics.
John Bailey
G1 Therapeutics
Chief Executive Officer
Jennifer Moses
G1 Therapeutics
Chief Financial Officer
Mark Avagliano
G1 Therapeutics
Chief Business Officer
Mark Velleca
G1 Therapeutics
Chief Executive Officer
Soma Gupta
G1 Therapeutics
Chief Commercial Officer
Rajesh Malik
G1 Therapeutics
Chief Medical Officer
Barclay Phillips
G1 Therapeutics
Chief Financial Officer
James Hanson
G1 Therapeutics